Company page

Guardant Health, Inc.

Guardant Health, Inc. is a publicly traded company listed under the ticker GH, operating in the American market. The company has a market capitalization of approximately $19.54 billion. Guardant Health specializes in advanced genomic testing for cancer, focusing on non-invasive blood tests to help guide treatment decisions.